Lewis Krauskopf
page
1
of
1
Analysis: Slow, costly process stymies generic biotech drugs
Mar 05, 2012 07:10 EST
LOS ANGELES (Reuters) - One of the pledges of the Obama administration's healthcare overhaul was to enable cheaper copies of expensive biotech drugs, but the savings may not be as deep or come as quickly as hoped.
Slow, costly process stymies generic biotech drugs
Mar 05, 2012 07:10 EST
LOS ANGELES (Reuters) - One of the pledges of the Obama administration's healthcare overhaul was to enable cheaper copies of expensive biotech drugs, but the savings may not be as deep or come as quickly as hoped.
FDA adding diabetes, memory loss warnings to statins
Feb 28, 2012 13:46 EST
(Reuters) - U.S. health regulators will add warnings to the labels of widely used cholesterol lowering drugs, such as Lipitor, saying they may raise levels of blood sugar and could cause memory loss.
FDA adds diabetes, memory loss warnings to statins
Feb 28, 2012 13:46 EST
(Reuters) - U.S. health regulators will add warnings to the labels of widely used cholesterol lowering drugs, such as Lipitor, to indicate that they may raise levels of blood sugar and could cause memory loss.
FDA adds diabetes, memory loss warnings to statins
Feb 28, 2012 13:46 EST
(Reuters) - U.S. health regulators will add warnings to the labels of widely used cholesterol lowering drugs, such as Lipitor, to indicate that they may raise levels of blood sugar and could cause memory loss.
Express Scripts says moving on without Walgreen
Feb 23, 2012 11:35 EST
(Reuters) - Express Scripts Inc <ESRX.O> said on Thursday it was moving forward successfully without Walgreen Co <WAG.N> in its pharmacy network, citing wide support from clients.
J&J recalls infant Tylenol over dosing system flaw
Feb 17, 2012 08:49 EST
(Reuters) - Johnson & Johnson said it is recalling about 574,000 bottles of its grape-flavored liquid infant Tylenol in the United States after parents complained about problems with the dosing system.
J&J recalls infant Tylenol due to bottle flaw
Feb 17, 2012 08:49 EST
(Reuters) - Johnson & Johnson said it was recalling its entire U.S. supply of infant Tylenol after parents complained about problems with a new dosing system, the latest in a string of recalls for the healthcare giant.
Astra takes brand cancer drug straight to patients
Feb 16, 2012 16:58 EST
(Reuters) - AstraZeneca Plc is selling breast cancer drug Arimidex directly to U.S. patients, offering an option for people who want to pay for the brand instead of generic versions.
Insurers see costs in Obama birth control rule
Feb 16, 2012 15:14 EST
(Reuters) - The Obama administration maintains that its plan to have health insurers pay for birth control offered to employees of religious groups won't end up costing the industry. But insurers aren't so confident.
U.S. doctors scour drug supplies after fake Avastin found
Feb 15, 2012 19:40 EST
NEW YORK (Reuters) - A U.S. distributor of phony vials of the widely-used cancer drug Avastin aroused suspicion at doctor's offices as early as July, well before health regulators issued their own warning and sparked new alarm over counterfeit medicines.
Doctors scour drug supplies after fake Avastin found
Feb 15, 2012 19:40 EST
NEW YORK (Reuters) - A U.S. distributor of phony vials of the widely-used cancer drug Avastin aroused suspicion at doctor's offices as early as July, well before health regulators issued their own warning and sparked new alarm over counterfeit medicines.
FDA issues plan to avoid heparin contamination
Feb 10, 2012 07:41 EST
(Reuters) - U.S. health regulators issued recommendations to manufacturers to ensure the safe production of the blood-clot prevention drug heparin, four years after a contamination involving the widely used product set off concerns about the global pharmaceutical supply chain.
Illumina sets response timeline to Roche offer
Jan 27, 2012 10:39 EST
(Reuters) - U.S. gene sequencing company Illumina Inc said on Friday it will tell shareholders within 10 business days of its position on a $5.7 billion takeover bid from Swiss drugmaker Roche Holding AG.
UnitedHealth fourth-quarter profit tops views
Jan 19, 2012 06:20 EST
(Reuters) - UnitedHealth Group Inc <UNH.N> posted a higher-than-expected fourth-quarter profit, helped by greater membership across its array of health plans.
Thomson Reuters suspends sale of healthcare unit
Dec 22, 2011 09:01 EST
(Reuters) - News and information provider Thomson Reuters Corp <TRI.TO> <TRI.N> said it has pulled the sale of its healthcare business, as tough economic conditions made it difficult to fetch a good enough price.
FDA to review Pfizer rheumatoid arthritis drug
Dec 20, 2011 08:55 EST
(Reuters) - U.S. health regulators have accepted the application for Pfizer Inc's closely watched experimental rheumatoid arthritis drug, the drugmaker said on Tuesday.
States to weigh in on basic health coverage
Dec 16, 2011 14:42 EST
(Reuters) - U.S. health officials will allow states to select the basic set of medical benefits that must be offered by insurance plans participating in new exchanges mandated by the federal healthcare overhaul, the U.S. government said on Friday.
States to weigh in on basic health coverage
Dec 16, 2011 13:46 EST
(Reuters) - U.S. health officials will allow states to select the basic set of medical benefits that must be offered by insurance plans participating in new exchanges mandated by the federal healthcare overhaul, the U.S. government said on Friday.
States to weigh in on basic health coverage
Dec 16, 2011 13:06 EST
(Reuters) - U.S. health officials will allow states to select the basic set of medical benefits that must be offered by insurance plans participating in new exchanges mandated by the federal healthcare overhaul, the U.S. government said on Friday.
